References
- Hsu E, Cohen SP. Postamputation pain: epidemiology, mechanisms, and treatment. J Pain Res. 2013;6:121–136.
- McCormick Z, Chang-Chien G, Marshall B, et al. Phantom limb pain: a systematic neuroanatomical-based review of pharmacologic treatment. Pain Med. 2014;15:292–305.
- Sherman RA, Sherman CJ, Parker L. Chronic phantom and stump pain among American veterans: results of a survey. Pain. 1984;18:83–95.
- Whyte AS, Niven CA. Variation in phantom limb pain: results of a diary study. J Pain Symptom Manage. 2001;22:947–953.
- Kooijman CM, Dijkstra PU, Geertzen JH, et al. Phantom pain and phantom sensations in upper limb amputees: an epidemiological study. Pain. 2000;87:33–41.
- Giummarra MJ, Moseley GL. Phantom limb pain and bodily awareness: current concepts and future directions. Curr Opin Anaesthesiol. 2011;24:524–531.
- Pirowska A, Wloch T, Nowobilski R, et al. Phantom phenomena and body scheme after limb amputation: a literature review. Neurol Neurochir Pol. 2014;48:52–59.
- Wiech K, Kiefer RT, Töpfner S, et al. A placebo-controlled randomized crossover trial of the N-methyl-d-aspartic acid receptor antagonist, memantine, in patients with chronic phantom limb pain. Anesth Analg. 2004;98:408–413.
- Niraj S, Niraj G. Phantom limb pain and its psychologic management: a critical review. Pain Manag Nurs. 2014;15:349–364.
- Alviar MJ, Hale T, Dungca M. Pharmacologic interventions for treating phantom limb pain. Cochrane Database Syst Rev. 2011;(12):CD006380.
- Hackworth RJ, Tokarz KA, Fowler IM, et al. Profound pain reduction after induction of memantine treatment in two patients with severe phantom limb pain. Anesth Analg. 2008;107:1377–1379.
- Olivan-Blázquez B, Herrera-Mercadal P, Puebla-Guedea M, et al. Efficacy of memantine in the treatment of fibromyalgia: a double-blind, randomised, controlled trial with 6-month follow-up. Pain. 2014;155:2517–2525.
- Sinis N, Birbaumer N, Gustin S, et al. Memantine treatment of complex regional pain syndrome: a preliminary report of six cases. Clin J Pain. 2007;23:237–243.
- Forest Pharmaceuticals, Inc. Namenda® (memantine) [package insert]. St. Louis, MO; 2013.
- Schley M, Topfner S, Wiech K, et al. Continuous brachial plexus blockade in combination with the NMDA receptor antagonist memantine prevents phantom pain in acute traumatic upper limb amputees. Eur J Pain. 2007;11:299–308.
- Johnson JW, Kotermanski SE. Mechanism of action of memantine. Curr Opin Pharmacol. 2006;6:61–67.
- Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151:264–269.
- Kiefer RT, Wiech K, Topfner S, et al. Continuous brachial plexus analgesia and NMDA-receptor blockade in early phantom limb pain: a report of two cases. Pain Med. 2002;3:156–160.
- Neil MJE, Dale MC, Gillespie G. Successful use of memantine in the treatment of severe phantom limb pain: case report and review of the literature. Scott Med J. 2010;55:58.
- Maier C, Dertwinkel R, Mansourian N, et al. Efficacy of the NMDA-receptor antagonist memantine in patients with chronic phantom limb pain—results of a randomized double-blinded, placebo-controlled trial. Pain. 2003;103:277–283.
- Schwenkreis P, Maier C, Pleger B, et al. NMDA-mediated mechanisms in cortical excitability changes after limb amputation. Acta Neurol Scand. 2003;108:179–184.
- Nikolajsen L, Gottrup H, Kristensen AG, et al. Memantine (a N-methyl-d-aspartate receptor antagonist) in the treatment of neuropathic pain after amputation or surgery: a randomized, double-blinded, cross-over study. Anesth Analg. 2000;91:960–966.
- McCartney CJ, Sinha A, Katz J. A qualitative systematic review of the role of N-methyl-d-aspartate receptor antagonists in preventive analgesia. Anesth Analg. 2004;98:1385–1400.
- Rogers M, Rasheed A, Moradimehr A, Baumrucker SJ. Memantine (Namenda) for neuropathic pain. Am J Hosp Palliat Care. 2009;26:57–59.